Morgan Marhefka, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 400 Valley Rd Ste 105, Mt Arlington, NJ 07856 Phone: 973-770-7101 |
Ms. Jennifer Ann Marion, NP-C Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 400 Valley Rd Ste 102, Mt Arlington, NJ 07856 Phone: 973-770-7899 Fax: 973-770-7840 |
News Archive
After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus. In studies sponsored by the National Institutes of Health, evidence has been found that estrogen and progestin in hormone therapies increase the risk of breast cancer in post-menopausal women.
Cardiome Pharma Corp. today announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize AGGRASTAT® (tirofiban HCl) in selected European markets.
Newly published research, by investigators, at the North East England Stem Cell Institute (NESCI) in the journal Stem Cells reported the first successful treatment of eight patients with "Limbal Stem Cell Deficiency" (LSCD) using the patients' own stem cells without the need of suppressing their immunity.
Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed a 10-year lease agreement for a new 46,000-square-foot manufacturing facility in Pearland, Texas.
In an effort to reduce infections among patients, independent investigators are to carry out random spot checks on hospital hygiene.
› Verified 2 days ago